NCT01138072View on ClinicalTrials.gov

A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Infection, Human Immunodeficiency Virus
Interventions
DRUG

GSK2248761

200mg once daily

DRUG

Simvastatin

20 mg Simvastatin single dose

DRUG

Atorvastatin

20 mg atorvastatin single dose

DRUG

Rosuvastatin

10 mg rosuvastatin single dose

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01138072 - A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects. | Biotech Hunter | Biotech Hunter